Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00666432 · ClinicalTrials.gov registry record
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 3,500
- Enrollment target
NCT00666432 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 3,500 participants.
The verdict
NCT00666432 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 3,500 participants
- Enrollment target
Study Summary
Briefly, this multisite study is designed to identify endophenotypes (i.e., heritable biomarkers) associated with either schizophrenia or bipolar disorder alone, or both together. The subsequent genetic analyses will search genomic loci and candidate genes associated with each of the independent endophenotypes. This is a five site study that is slotted for NIMH funding.
Interventions
- OTHER This is an observational study model that is family based
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,500 participants |
| Start Date | 2008-05 |
| Est. Completion | 2019-11-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00666432
The ClinicalTrials.gov registry entry for NCT00666432 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which This is an observational study model that is family based is the first listed.
NCT00666432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00666432 about?
NCT00666432 is a clinical study titled "Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes". Briefly, this multisite study is designed to identify endophenotypes (i.e., heritable biomarkers) associated with either schizophrenia or bipolar disorder alone, or both together. The subsequent genetic analyses will search genomic loci and candidate genes associated with each of the independent end...
What is the current status of trial NCT00666432?
This trial is currently completed. The enrollment target is 3,500 participants. The study started on 2008-05. Estimated completion is 2019-11-22.
What interventions are being tested in trial NCT00666432?
The interventions under investigation include: This is an observational study model that is family based (OTHER).
Who is sponsoring clinical trial NCT00666432?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.